The Intel story being circulated is a financing story without the financing document. Until the claimed upsized raise can be tied to an SEC filing and its dilution can be calculated, the only defensible decision is to stay out.

INTC — AVOID

Why now. An August 14, 2026 review memo tested a claim that Intel planned a $15 billion equity raise and then upsized it to $20 billion to fund foundry expansion. The memo could not match that claim to a registration statement or prospectus, so the central fact behind the trade remains unsupported as of August 14, 2026 (SEC filings).

The evidence. The latest available regular-session close was $102.50 on August 14, 2026, versus a $104.48 open, $106.87 high and $102.05 low; volume was approximately 95.4 million shares that day (market data). That price action does not validate the alleged capital raise. More importantly, the reviewed material supplied no filing identifier, offer price, new-share count, use-of-proceeds schedule, current valuation framework, or balance-sheet bridge—each is necessary before a claimed $20 billion equity financing can support an investment case (Intel IR; SEC filings).

Levels & triggers. Do not use the current price as an entry level. The trigger to reconsider is a filed registration statement or prospectus that confirms the gross proceeds, offer price, share count and use of proceeds; only then can dilution and the return on foundry spending be underwritten. A financing document showing attractive economics and a credible path to incremental cash returns would move the call toward ACCUMULATE. The thesis is killed outright if the filing never appears, or if the verified terms imply dilution without a measurable cash-return hurdle (SEC search).

Horizon. This AVOID applies until the financing claim is verified and the resulting dilution can be reconciled to Intel’s filed financials; it is an event-driven call, not a next-week price forecast.

The bear case to this call. Intel may in fact have secured unusually favorable capital for a foundry build-out whose long-duration returns exceed the dilution. If so, waiting for the filing could sacrifice some upside—but paying that opportunity cost is preferable to underwriting a $20 billion transaction whose terms have not been established (Intel IR).

What I’m watching: the first Intel registration statement, prospectus or 8-K that confirms—or disproves—the claimed financing and provides enough detail to calculate dilution.

Sources

• Intel SEC filings
• SEC company search
• Intel investor relations
• Massive market data

Independent equity analysis, for information only, not investment advice.